Market Sentiment for PODD

Live Market Sentiment

Positive (0.1419)

(Latest daily score)

Predicted Return

30.76%

7-day sentiment average

Advisory Opinion

Buy

Derived from sentiment trend

News Items (period)

740

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-04-03	Insulet (PODD): 3 Reasons We Love This Stock	StockStory	Positive (0.1419)
2026-04-01	Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026	Business Wire	Neutral (0.0086)
2026-04-01	Does Insulet (PODD) Elevate Its Diabetes Tech Edge With Panos Steering Global Commercial Strategy?	Simply Wall St.	Strong Positive (0.6307)
2026-03-31	MiniMed initiated with ‘Buy’ rating by Bank of America on pipeline-driven growth outlook	Proactive	Positive (0.3339)
2026-03-31	Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks	StockStory	Neutral (0.0931)
2026-03-31	Can Boston Scientific Stock Surge 40% From Here?	Trefis	Strong Positive (0.8439)
2026-03-30	Insulet Appoints Mike Panos as Chief Commercial Officer	Business Wire	Neutral (0.0018)
2026-03-30	Truist Maintains Insulet Corporation (PODD) Buy Rating Despite Device Correction Announcement	Insider Monkey	Strong Positive (0.7135)
2026-03-27	Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know	StockStory	Strong Negative (-0.6163)
2026-03-27	3 S&P 500 Stocks for Long-Term Investors	StockStory	Neutral (0.0082)